(Q43296433)

English

Improvement of mitochondrial toxicity in patients receiving a nucleoside reverse-transcriptase inhibitor-sparing strategy: results from the Multicenter Study with Nevirapine and Kaletra (MULTINEKA).

scientific article published in September 2009

Statements

Improvement of mitochondrial toxicity in patients receiving a nucleoside reverse-transcriptase inhibitor-sparing strategy: results from the Multicenter Study with Nevirapine and Kaletra (MULTINEKA). (English)
0 references
0 references
0 references
0 references
Josep Cucurull
Pere Domingo
MULTINEKA Study Group
1 September 2009
892-900

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit